Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): Comparison between a leukemia cell line with high MRP gene expression and its parental cell line

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 1, 2001, Pages 17-23

  Li, X F ^a   Tonami, N ^a   Kinuya, S ^a   Yokoyama, K ^a   Konishi, S ^a   Ma, Y Y ^a   Watanabe, N ^a   Shuke, N ^a   Bunko, H ^a   Michigishi, T ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Multidrug resistance; Multidrug resistance associated protein; Technetium 99m tetrofosmin; Verapamil

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN; TETROFOSMIN TC 99M; VERAPAMIL;

ARTICLE; CANCER RESISTANCE; CELL STRAIN HL 60; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035078871     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497801750095961     Document Type: Article

References (22)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. Mechanism of multidrug resistance
3. The human multidrug resistance (mdr1). cDNA cloning and transcription initiation
4. Pharmacology of drugs that alter multidrug resistance in cancer
5. Function imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex
6. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multidrug resistant breast tumor cells
7. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy
8. Influence of the heterogeneity of P-glycoprotein-expression on technetium-99m-MIBI uptake in breast cancer
9. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
10. Tc-99m-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
11. Comparison of the kinetic of active efflux of Tc-99m-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance phenotype
12. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells
13. Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: In vitro analysis with T1-201, Tc-99m-sestamibi and Tc-99m-tetrofosmin in human bladder cancer cells and human leukocytes
14. Technetium-99m-tetrofosmin as a new rediopharmaceutical for myocardial perfusion imaging
15. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: Correlation with mdr gene expression
16. 99mTc-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: In vitro and in vivo studies in a rat breast tumor cell line and it doxorubicin-resistant variant
17. Differences between accumulation of Tc-99m-MIBI and T1-201-thallous chloride in tumor cells: Role of P-glycoprotein
18. Effects of ion channel modulators in the influx and efflux of Tc-99m-MIBI
19. Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells
20. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells
21. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines
22. Effects of MDR1 and MDR3 P-glycoproteins, MRP, and BCRP/MXR/ABCP on the transport of 99mTc-tetrofosmin